Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Financial planning is vital for a successful retirement. Discover the reasons why it matters for your long-term financial health.
24,228 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Housing turnover has slipped to multi-decade lows, pushing lenders and agents to rethink pricing. A new framework gui...
SpaceX may steal headlines, but the real action for investors is in the earnings reports of BlackSky, Redwire, and Ro...
Learn how xometry (xmtr) 2026 earnings shape the investment case. We break down the numbers, strategy, and risks, wit...
Learn how to analyze Baer’s Q1 2026 earnings call. This guide breaks down the numbers, guidance, and what it means fo...
BitGo’s Q1 2026 earnings reveal more than headline numbers. This guide translates the transcript into actionable insi...
Cloudflare stock has seen a sharp pullback. This guide breaks down the factors behind the drop, what it means for the...
Europe’s top AI startups are accelerating moves to the U.S. amid a flood of AI-focused funding. The trend is reshapin...
A sharp 27% drop for AppLovin stock has investors weighing risk and reward. This guide breaks down the business, the ...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Bitget unveils Reality, a new tokenization platform delivering tokenized access to select U.S. stocks and ETFs as mar...
Five weeks after Vanguard split three ETFs, VGT led the gauges, turning a post-split move into a meaningful performan...